Doç. Dr. Emine Gültürk

Doctor and researcher Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi İstanbul
Myeloproliferative DisordersThrombosisLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Myeloproliferative Disorders 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Thrombosis 2 publications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • InstitutionBakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workMyeloproliferative DisordersExtracted from 4 publications · Model version —From source
  • Publications58 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0003-2836-6162ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bakirkoysadikonukeah.saglik.gov.tr/TR-1482136/doktorlarimiz.html#emine-gulturksaglik.gov.tr

Scientific work

Publications on Myeloproliferative Disorders

58 publications

  1. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex

  2. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

    DOI 10.55730/1300-0144.6184 PMID 42058976 Open-access full textSource: OpenAlex

  3. Innovative Cancer Drugs: Medicolegal Assessments on Efficacy and Necessity

    Sakarya Medical Journal, 2026

    DOI 10.31832/smj.1798059 Open-access full textSource: ORCID

  4. CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.027 PMID 41821563 Open-access full textSource: ORCID

  5. Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13465-6 PMID 42056949 2 citations (Europe PMC) Open-access full textSource: ORCID

  6. Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

    Nigerian Journal of Clinical Practice, 2025

    DOI 10.4103/njcp.njcp_499_24 PMID 40462333 Open-access full textSource: OpenAlex

  7. Psychiatric Manifestations in Polycythemia Vera: A Case of Refractory Delirium and Psychosis Responding to Hematological Treatment

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0060 PMID 40297865 Open-access full textSource: Europe PMC

  8. Atypic Primary Ovarian Lymphoma Presenting with Hypercalcemia: A Rare Case Report

    Bezmialem Science, 2025

    DOI 10.14235/bas.galenos.2025.08216 Open-access full textSource: OpenAlex

  9. Exploring the potential of blood and urine protein electrophoresis in predicting 1-year mortality in acute kidney injury

    Plos One, 2025

    DOI 10.1371/journal.pone.0327044 PMID 40561005 1 citation (Europe PMC) Open-access full textSource: ORCID

  10. The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

    Immunologic Research, 2025

    DOI 10.1007/s12026-025-09672-z PMID 40768060 1 citation (Europe PMC) Source: ORCID

View all 58 publications